InspireMD, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| RenTech | quant | 17.6K | $28.70K | 0.00% | New | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-11upcoming | -0.20 | — | — |
| 2026-05-04 | -0.18 | -0.16 | +11.11% |
| 2026-03-18 | -0.19 | -0.14 | +27.58% |
| 2025-11-04 | -0.19 | -0.17 | +12.82% |
| 2025-08-04 | -0.26 | -0.26 | — |
| 2025-05-08 | -0.20 | -0.22 | -10.00% |
| 2025-03-12 | -0.19 | -0.18 | +7.69% |
| 2024-11-12 | -0.20 | -0.16 | +20.00% |
| 2024-08-05 | -0.19 | -0.22 | -15.79% |
| 2024-05-13 | -0.15 | -0.21 | -40.00% |
| 2024-03-05 | -0.19 | -0.13 | +33.33% |
| 2023-11-06 | -0.15 | -0.15 | +3.23% |
| 2023-08-07 | -0.30 | -0.24 | +20.00% |
| 2023-05-15 | -0.68 | -0.53 | +22.06% |
| 2023-03-30 | -0.84 | -0.60 | +28.57% |
| 2022-11-07 | -0.73 | -0.58 | +20.55% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| NSPR | -20.00% | -45.88% | -48.31% | -64.06% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -22.97% | -41.24% | -44.87% | -76.75% |